Astrazeneca Pharma India Ltd
NSE: ASTRAZEN BSE: 506820
₹8760
(-0.63%)
Wed, 11 Mar 2026, 08:33 pm
Market Cap220.04B
PE Ratio109.01
Dividend0.37
Health Technology
Pharmaceuticals: Major
24.5KCompany History
1979
- Company incorporated on July 11; Certificate of Commencement obtained November 6.
- Promoted jointly by Astra Pharmaceuticals AB, Sweden and IDL Chemicals Ltd.
1980
- Enters technical collaboration with Astra Pharmaceuticals AB, Sweden for know-how.
- Undertakes project for manufacture of basic drugs, formulations, fine and industrial chemicals at Yelahanka, Bangalore.
1982
- Issues shares: 2,000 to promoters; 24,98,000 at par; 6,43,235 each to Astra and IDL; 3,78,830 to Indian directors/shareholders/employees; 8,32,700 to public.
- Pharmaceuticals and chemicals plant commissioned in February.
1988
- Launches Sensorcaine, Theobric, Restomycin, Bromenyl, Febafen, Prostodin, Selopres, Betaloc Durules, Tripres, Sensorcaine Spinal, Bricanyl Nebulising Solution, Pulmicort Inhaler, Bricanyl Inhaler, Spacehaler.
- Plans in-house facilities for inhalation therapy and prostaglandin formulations.
1991
- Launches PIMIPROST prostaglandin for safe motherhood.
1992
- Launches Cerviprime Gel and Plendil; proposes launches of Ramace, Rhinocort, Imdur.
1994
- Launches Ramace, Imdur, Rhinocort.
1995
- Issues 2,500,000 bonus shares in 1:1 proportion.
1996
- Introduces jumbo packs of Pulmicort and Bricanyl inhalers, low dose aspirin, Imdur 30 mg.
1997
- Launches new products: Xylocaine Spray, Stop-it, Mimbid, Linctus-D, Rhinocort Aqua, Rejois, Cellubril.
- Establishes production facilities for aerosols and soft gelatin capsules.
- Astra-IDL joint venture faces prolonged litigation between promoters.
1998
- Astra-IDL receives Analyst Award from ICFAI.
- Astra had set up 100% research facility in Bangalore three years ago.
1999
- Hindujas seek new partners to replace AstraZeneca in Astra-IDL joint venture.
2000
- UB Bioteck ties up with Astra IDL to market anti-obesity nutraceutical.
- Appoints D.E. Udwadia as Chairman.
2001
- Crisil places 'FAA' rating on fixed deposit programme with positive watch.
- Astra Sweden acquires 51.50% equity, making company its subsidiary in AstraZeneca Group.
- Managing Director A.R. Hegde resigns.
- Company renamed AstraZeneca Pharma India Ltd; Lars Walan appointed MD effective April 2.
2002
- Ties up with Avestha for tuberculosis drug research.
- Makes open offer to acquire 43% stake in AstraZeneca Pharma India Ltd.
- Government approves FDI proposal increasing stake from 56.69% to 100% for Rs. 82 crore.
- Astra Pharma acquires 32,800 equity shares of AstraZeneca.
2003
- Astra Pharma and AstraZeneca jointly acquire less than 4% additional equity in AstraZeneca Pharma India Ltd.
- Tom McKillop inaugurates R&D centre in Bangalore for $40 million.
- Approaches government for Exclusive Marketing Rights for two new anti-cancer drugs.
- Board accepts resignation of Mr. J G Zetterberg effective May 2004.
2006
- AstraZeneca acquires Eli Lilly's Vancocin brand.
- Company splits share face value from Rs 10 to Rs 2.
2007
- Appoints Mr. Ruud Dobber as Director.
2010
- AstraZeneca and Bristol-Myers Squibb launch Onglyza (saxagliptin) for type 2 diabetes in India.
- Appoints Ms. Anita Zutshi as CFO.
2011
- AstraZeneca halts late-stage trial of Zibotentan for prostate cancer.
- Appoints Mr. Himanshu Agarwal as CFO.
2012
- AstraZeneca Excellence in Chemistry Awards 2011.
- AstraZeneca and Cellworks collaborate for tuberculosis treatment.
- AstraZeneca launches BRILINTA (ticagrelor) in India.
2013
- AstraZeneca to acquire Bristol-Myers Squibb's share of global diabetes alliance assets.
- AstraZeneca enters co-promotion agreement with Janssen in Japan for prostate cancer treatment.
2014
- FDA approves FARXIGA (dapagliflozin) for AstraZeneca and Bristol-Myers Squibb.
- AstraZeneca and MRC enter strategic collaboration for early drug discovery centre in Cambridge, UK.
- AstraZeneca and Roche announce partnership for companion diagnostic test for AZD9291.
- Company shifts registered office to Manyata Embassy Business Park, Bangalore.
2015
- AstraZeneca Pharma India Ltd and Dr Reddy’s Laboratories enter distribution agreement for saxagliptin and metformin combination for type 2 diabetes.
- AstraZeneca Pharma launches type-2 diabetes treatment drug.
- BRILIQUE (ticagrelor) receives positive EU CHMP opinion for extended heart attack treatment.
- AstraZeneca completes acquisition of ZS Pharma.
- AstraZeneca opens new manufacturing facility in Russia.
2017
- AstraZeneca Pharma receives import permission for inhaler powder.
- AstraZeneca Pharma receives approval for Osimertinib Tablet.
2018
- AstraZeneca Pharma India Ltd receives DCGI permission for Durvalumab.
2021
- AstraZeneca partners with DocOn to digitize healthcare clinics across India.
- AstraZeneca and Rajiv Gandhi Cancer Institute launch Project Chariot for CLL diagnosis and treatment.
- AstraZeneca launches Clinical Data and Insights division in India.
2022
- AstraZeneca Pharma receives CDSCO approval for Dapagliflozin tablets.
2023
- AstraZeneca inaugurates Centre of Excellence at Manipal Hospital Goa for severe asthma patients.
- AstraZeneca India partners with Roche Diagnostics India to improve breast cancer diagnostic testing.
- Government of Karnataka signs MoU with AstraZeneca India to accelerate lung cancer testing.
2024
- AstraZeneca Pharma India Ltd and Mankind Pharma Ltd announce collaboration for exclusive distribution of Symbicort in India.
- AstraZeneca India receives CDSCO approval for Durvalumab additional indication.
- AstraZeneca and Vaayu Chest & Sleep Center collaborate to enhance respiratory care for severe asthma patients in Bengaluru.
- AstraZeneca receives CDSCO approval to import and market Andexanet Alfa for critical bleeding conditions.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800